Personalized bacteriophage therapy for difficult-to-treat infections.
Jonathan Iredell, Holly Sinclair, Ameneh Khatami
Author Information
- Jonathan Iredell: Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia. jonathan.iredell@sydney.edu.au. ORCID
- Holly Sinclair: Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
- Ameneh Khatami: Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
No abstract text available.
- Summers, W. C. Bacteriophage 2, 130–133 (2012).
[DOI: 10.4161/bact.20757]
- Pirnay, J.-P. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-024-01705-x (2024).
[DOI: 10.1038/s41564-024-01705-x]
- Uyttebroek, S. et al. Lancet Infect. Dis. 22, e208–e220 (2022).
[DOI: 10.1016/S1473-3099(21)00612-5]
- Jault, P. et al. Lancet Infect. Dis. 19, 35–45 (2019).
[DOI: 10.1016/S1473-3099(18)30482-1]
- Berkson, J. D. et al. Nat. Commun. 15, 2993 (2024).
[DOI: 10.1038/s41467-024-47192-w]
- Champagne-Jorgensen, K., Luong, T., Darby, T. & Roach, D. R. Trends Microbiol. 31, 1058–1071 (2023).
[DOI: 10.1016/j.tim.2023.04.008]
- Dedrick, R. M. et al. Clin. Infect. Dis. 76, 103–112 (2023).
[DOI: 10.1093/cid/ciac453]
- Schooley, R. T. et al. Antimicrob. Agents Chemother. 61, e00954–17 (2017); erratum 62, e02221-18 (2018).
Phage Therapy
Humans
Precision Medicine
Bacteriophages
Bacterial Infections
